A vaccine in 12-18 months may not be realistic but is hopeful. First, the particular type of vaccine that may work best is determined. Then, there are human clinical trials. There is a lot of safety testing. Then, larger effects are observed such as side effects and at which dosages they come up. Then, testing and monitoring come about even after the vaccine is released. Some potential advantages that could speed up the vaccine process include traditional approaches, newer technologies, newer biotechnology-based methods, private companies, and scientists are working together. There may be an unconventional study design according to the Journal of Infectious Diseases and healthy people without chronic conditions in their twenties may opt for “human challenge study.” Possible coronavirus treatments are being developed. These include remdesivir, some drugs that may dampen the immune system’s effects, and convalescent plasma (antibodies and proteins in it).
